Low-temperature improved-throughput method for analysis of brain fatty acids and assessment of their post-mortem stability

Journal of Neuroscience Methods
Thomas FraserSeth Love

Abstract

Deficiency of docosahexaenoic acid (DHA) and other omega-3 (omega3) fatty acids may constitute an alterable risk factor for Alzheimer's disease (AD). Mechanisms of potential involvement of DHA in the disease process have been postulated primarily from studies in vitro and in mouse models of AD. Information on the fatty acid profile of the brain in AD itself is limited and in some respects contradictory. Interpretation of the findings is complicated by the diversity of methods used in previous studies and a lack of information as to the effect of post-mortem delay on the results. Here we report the development of a simple and highly reproducible method that enables relatively high-throughput measurement of the fatty acid composition in samples of brain tissue and using this method we have demonstrated that there is no significant change in fatty acid composition under conditions designed to model post-mortem delay of up to 3 days at 4 degrees C (or even at room temperature). The development of this method and the observation that delay of up to 3 days has no effect on fatty acid content will facilitate further studies of fatty acid composition on large cohorts of post-mortem brains.

References

Sep 1, 1991·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·I L KweeW G Ellis
Mar 3, 1998·Neurochemical Research·M R PrasadW R Markesbery
May 24, 2000·Proceedings of the National Academy of Sciences of the United States of America·T FarkasJ E Halver
Mar 30, 2002·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·C Leigh BroadhurstWalter F Schmidt
Oct 26, 2002·BMJ : British Medical Journal·Pascale Barberger-GateauSerge Renaud
Mar 26, 2003·The British Journal of Nutrition·A M TullyM J Gibney
Jul 23, 2003·Archives of Neurology·Martha Clare MorrisJulie Schneider
Mar 24, 2004·Chemistry and Physics of Lipids·Kathleen S MontineThomas J Montine
May 18, 2004·Nature Biotechnology·Baoxiu QiColin M Lazarus
Oct 2, 2004·Progress in Lipid Research·Raymond C Valentine, David L Valentine
Feb 1, 2005·Annals of the New York Academy of Sciences·Greg M ColeSally A Frautschy
Mar 25, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Giselle P LimGreg M Cole
May 4, 2005·Reproduction, Nutrition, Development·Genevieve Young, Julie Conquer
Sep 10, 2005·The Journal of Clinical Investigation·Walter J LukiwNicolas G Bazan
Nov 1, 2006·Biochemical Society Transactions·W J Lukiw, N G Bazan
Jan 30, 2007·Journal of Neurochemistry·Akhlaq A FarooquiTahira Farooqui
Jun 15, 2007·Nature·Jan M SchwabCharles N Serhan

❮ Previous
Next ❯

Citations

Oct 1, 2013·Lancet Neurology·Neshika SamarasekeraJames W Ironside
Sep 18, 2010·Brain Research·Emma L AshbySeth Love
Jul 25, 2019·Journal of Neuroendocrinology·Oscar Hidalgo-LanussaGeorge E Barreto

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.